# EBUS-TBNA vs Flex 19G EBUS-TBNA

> **NCT02592837** · NA · COMPLETED · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 250 (actual)

## Conditions studied

- Lymphadenopathy
- Lung Cancer
- Sarcoidosis
- Lymphoma

## Interventions

- **DEVICE:** Flexible 19G EBUS-TBNA needle
- **DEVICE:** 21G EBUS-TBNA needle

## Key facts

- **NCT ID:** NCT02592837
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-11-14
- **Final completion:** 2017-12-14
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592837, "EBUS-TBNA vs Flex 19G EBUS-TBNA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02592837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*